Arterial Stiffness Increases Over Time in Relation to Lung Diffusion Capacity: A Longitudinal Observation Study in...

Area of Science:

• Cardiology
• Pulmonology
• Biomedical Engineering

Background:

• Cardiovascular disease is a leading cause of mortality in COPD patients.
• Arterial stiffness is an independent predictor of mortality and cardiovascular events.
• Previous studies suggest increased arterial stiffness in COPD, but longitudinal data on predictors are limited.

Purpose of the Study:

• To assess the longitudinal changes in arterial stiffness, measured by augmentation index (AIx), in COPD patients.
• To identify clinical predictors associated with the progression of arterial stiffness in this cohort.

Main Methods:

• Annual measurement of AIx using applanation tonometry over up to 7 years.
• Regular assessment of lung function, blood gases, systemic inflammation, lipids, and blood pressure.
• Mixed-effects modeling to analyze the association between AIx changes and potential predictors.

Main Results:

• AIx showed a significant annual increase of 0.91% in COPD patients.
• Declines in diffusion capacity (DLco), lower low-density lipoprotein (LDL), and higher high-sensitivity C-reactive protein (hsCRP) were independently associated with increasing AIx.
• The study included 76 patients with a mean age of 62.4 years.

Conclusions:

• COPD patients experience a significant longitudinal increase in arterial stiffness.
• Worsening emphysema severity (DLco), systemic inflammation (hsCRP), and dyslipidemia (LDL) predict the progression of arterial stiffness.
• These findings highlight key factors contributing to cardiovascular risk in COPD.